Trillium Therapeutics Inc (TRIL)

[mr5874]

Nice annual (special) shareholder meeting today. Based on Jan's upbeat tone throughout the call, I get the feeling he's sitting on a good hand, and he's holding his cards close to the vest for now.

As you point out, this space is heating up - especially with the GILD/FTSV acquisition early in the year. At a bare minimum we are a valuation gap play, and there is plenty of room to run here.

Assuming the market doesn't crumble, I personally could see this climbing into the double digits and could go vertical based on the 621 mid-year read out. If the data is positive with additional CRs/PRs, this may start a bidding war for those who lost out on the $4.9B GILD/FTSV deal ($95.50 pps). If TRIL fetched $2.5B, we would be sitting at roughly $30. Wouldn't complain, but it's very possible that GILD bought the wrong CD47 company, and if 621 and 622 continue to show statistically meaningful data, this company could be on par or have a greater valuation than FTSV.

Time will tell... thanks for sharing your thoughts. That's what this board is all about!